The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease

Parkinson’s disease is the second most common neurodegenerative disorder; it affects 1% of the population over the age of 65. The number of people with Parkinson’s disease is set to rapidly increase due to changing demographics and there is an unmet clinical need for disease-modifying therapies. The...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neural Regen Res
Asıl Yazarlar: Goulding, Susan R., Sullivan, Aideen M., O'Keeffe, Gerard W., Collins, Louise M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wolters Kluwer - Medknow 2020
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7059567/
https://ncbi.nlm.nih.gov/pubmed/31997802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1673-5374.274327
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller